Literature DB >> 18981739

Current concepts of neurohormonal activation in heart failure: mediators and mechanisms.

Christopher S Lee1, Nancy C Tkacs.   

Abstract

Neurohormonal activation is a commonly cited array of phenomena in the body's physiologic response to heart failure. Although various neurohormones and pharmacologic agents that moderate their pathophysiologic effects have been reviewed in the nursing literature, both the mechanisms of neurohormonal system activation and cellular and organ system effects have been described only in brief. Accordingly, this article reviews mechanisms of neurohormonal activation and describes cellular and cardiovascular effects of the (1) sympathetic nervous system, (2) renin-angiotensin-aldosterone system, (3) kallikrein-kininogen-kinin system, (4) vasopressinergic system, (5) natriuretic peptide systems, and (6) endothelin in the context of heart failure. This article implicitly details the physiologic basis for numerous current and potential future pharmacologic agents used in the management of heart failure. It is intended that this article be used as a reference for advanced clinical nursing practice, research, and education.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981739     DOI: 10.1097/01.AACN.0000340718.93742.c4

Source DB:  PubMed          Journal:  AACN Adv Crit Care        ISSN: 1559-7768


  19 in total

Review 1.  Biomarkers for risk prediction in acute decompensated heart failure.

Authors:  A Rogier van der Velde; Wouter C Meijers; Rudolf A de Boer
Journal:  Curr Heart Fail Rep       Date:  2014-09

Review 2.  Is Heart Rate a Norepiphenomenon in Heart Failure?

Authors:  Mark Hensey; James O'Neill
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

3.  Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat.

Authors:  Nuno Miguel Pires; Bruno Igreja; Eduardo Moura; Lyndon Christopher Wright; Maria Paula Serrão; Patrício Soares-da-Silva
Journal:  Hypertens Res       Date:  2015-04-09       Impact factor: 3.872

Review 4.  Alpha2-adrenoceptors in adrenomedullary chromaffin cells: functional role and pathophysiological implications.

Authors:  Antonio R Artalejo; Luis Alcides Olivos-Oré
Journal:  Pflugers Arch       Date:  2017-08-23       Impact factor: 3.657

5.  Exploring the relationship between β-adrenergic receptor kinase-1 and physical symptoms in heart failure.

Authors:  Quin E Denfeld; James O Mudd; Wohaib Hasan; Jill M Gelow; Shirin O Hiatt; Kerri Winters-Stone; Christopher S Lee
Journal:  Heart Lung       Date:  2018-05-24       Impact factor: 2.210

6.  Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat.

Authors:  Bruno Igreja; Nuno Miguel Pires; Maria João Bonifácio; Ana Isabel Loureiro; Carlos Fernandes-Lopes; Lyndon Christopher Wright; Patrício Soares-da-Silva
Journal:  Hypertens Res       Date:  2014-10-09       Impact factor: 3.872

7.  Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α(2) -adrenoceptor-catecholamine production axis in heart failure.

Authors:  G Rengo; A Lymperopoulos; C Zincarelli; Gd Femminella; D Liccardo; G Pagano; C de Lucia; A Cannavo; P Gargiulo; N Ferrara; P Perrone Filardi; Wj Koch; D Leosco
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 8.  The influence of heart failure self-care on health outcomes: hypothetical cardioprotective mechanisms.

Authors:  Christopher S Lee; Nancy C Tkacs; Barbara Riegel
Journal:  J Cardiovasc Nurs       Date:  2009 May-Jun       Impact factor: 2.083

Review 9.  Increased mortality after an acute heart failure episode: new pathophysiological insights from the RELAX-AHF study and beyond.

Authors:  Gad Cotter; Olga Milo; Beth A Davison
Journal:  Curr Heart Fail Rep       Date:  2014-03

10.  Effect of percutaneous renal sympathetic nerve radiofrequency ablation in patients with severe heart failure.

Authors:  Qiming Dai; Jing Lu; Benwen Wang; Genshan Ma
Journal:  Int J Clin Exp Med       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.